Eintrag weiter verarbeiten
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-c...
Gespeichert in:
Zeitschriftentitel: | Amyloid |
---|---|
Personen und Körperschaften: | , , , , , , |
In: | Amyloid, 26, 2019, 2, S. 74-84 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Informa UK Limited
|
Schlagwörter: |
author_facet |
Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl |
---|---|
author |
Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl |
spellingShingle |
Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl Amyloid Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study Internal Medicine |
author_sort |
gamez, josep |
spelling |
Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl 1350-6129 1744-2818 Informa UK Limited Internal Medicine http://dx.doi.org/10.1080/13506129.2019.1597702 Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study Amyloid |
doi_str_mv |
10.1080/13506129.2019.1597702 |
facet_avail |
Online |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xMzUwNjEyOS4yMDE5LjE1OTc3MDI |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xMzUwNjEyOS4yMDE5LjE1OTc3MDI |
institution |
DE-15 DE-Pl11 DE-Rs1 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 |
imprint |
Informa UK Limited, 2019 |
imprint_str_mv |
Informa UK Limited, 2019 |
issn |
1350-6129 1744-2818 |
issn_str_mv |
1350-6129 1744-2818 |
language |
English |
mega_collection |
Informa UK Limited (CrossRef) |
match_str |
gamez2019transthyretinstabilizationactivityofthecatecholomethyltransferaseinhibitortolcaponesom0226inhereditaryattramyloidosispatientsandasymptomaticcarriersproofofconceptstudy |
publishDateSort |
2019 |
publisher |
Informa UK Limited |
recordtype |
ai |
record_format |
ai |
series |
Amyloid |
source_id |
49 |
title |
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_unstemmed |
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_full |
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_fullStr |
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_full_unstemmed |
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_short |
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_sort |
transthyretin stabilization activity of the catechol-<i>o</i>-methyltransferase inhibitor tolcapone (som0226) in hereditary attr amyloidosis patients and asymptomatic carriers: proof-of-concept study |
topic |
Internal Medicine |
url |
http://dx.doi.org/10.1080/13506129.2019.1597702 |
publishDate |
2019 |
physical |
74-84 |
description |
|
container_issue |
2 |
container_start_page |
74 |
container_title |
Amyloid |
container_volume |
26 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792344876899106818 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T17:14:02.564Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Transthyretin+stabilization+activity+of+the+catechol-O-methyltransferase+inhibitor+tolcapone+%28SOM0226%29+in+hereditary+ATTR+amyloidosis+patients+and+asymptomatic+carriers%3A+proof-of-concept+study&rft.date=2019-04-03&genre=article&issn=1744-2818&volume=26&issue=2&spage=74&epage=84&pages=74-84&jtitle=Amyloid&atitle=Transthyretin+stabilization+activity+of+the+catechol-%3Ci%3EO%3C%2Fi%3E-methyltransferase+inhibitor+tolcapone+%28SOM0226%29+in+hereditary+ATTR+amyloidosis+patients+and+asymptomatic+carriers%3A+proof-of-concept+study&aulast=Insa&aufirst=Ra%C3%BAl&rft_id=info%3Adoi%2F10.1080%2F13506129.2019.1597702&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792344876899106818 |
author | Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl |
author_facet | Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl, Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl |
author_sort | gamez, josep |
container_issue | 2 |
container_start_page | 74 |
container_title | Amyloid |
container_volume | 26 |
description | |
doi_str_mv | 10.1080/13506129.2019.1597702 |
facet_avail | Online |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xMzUwNjEyOS4yMDE5LjE1OTc3MDI |
imprint | Informa UK Limited, 2019 |
imprint_str_mv | Informa UK Limited, 2019 |
institution | DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4 |
issn | 1350-6129, 1744-2818 |
issn_str_mv | 1350-6129, 1744-2818 |
language | English |
last_indexed | 2024-03-01T17:14:02.564Z |
match_str | gamez2019transthyretinstabilizationactivityofthecatecholomethyltransferaseinhibitortolcaponesom0226inhereditaryattramyloidosispatientsandasymptomaticcarriersproofofconceptstudy |
mega_collection | Informa UK Limited (CrossRef) |
physical | 74-84 |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | Informa UK Limited |
record_format | ai |
recordtype | ai |
series | Amyloid |
source_id | 49 |
spelling | Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl 1350-6129 1744-2818 Informa UK Limited Internal Medicine http://dx.doi.org/10.1080/13506129.2019.1597702 Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study Amyloid |
spellingShingle | Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl, Amyloid, Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study, Internal Medicine |
title | Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_full | Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_fullStr | Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_full_unstemmed | Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_short | Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_sort | transthyretin stabilization activity of the catechol-<i>o</i>-methyltransferase inhibitor tolcapone (som0226) in hereditary attr amyloidosis patients and asymptomatic carriers: proof-of-concept study |
title_unstemmed | Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study |
topic | Internal Medicine |
url | http://dx.doi.org/10.1080/13506129.2019.1597702 |